Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases

NCT02602327 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT02602327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02602327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases
Lead sponsor
University of California, San Francisco
Phase
Phase 1
Overall status
Completed
Start date
January 9, 2017
Completion date
August 31, 2021
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer, liver metastases, rectal cancer